Pivotal will attend again the ASCO annual meeting
The American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, (USA)
Pivotal, represented by members of our Senior Management, will attend, as usual, the American Society...
News
Pivotal starts enrolment in a phase II clinical trial in patients with Von Hippel-Lindau (VHL) disease developing renal cell cancer
New collaboration aims to further accelerate the delivery of novel treatments for difficult-to-treat cancers
Pivotal has enrolled the first patients in a recently awarded new phase II trial in...
Pivotal´s milestone in the European Society for Medical Oncology conference
ESMO 2019 annual congress will take place in Barcelona, from the 27th of September to 1st October
On Tuesday, October 23rd, the European Society for Medical Oncology Congress (<a...
Pivotal participates in the 2018 European Society for Medical Oncology (ESMO) congress in Munich, Germany
Pivotal and ESMO working on different levels to improve prevention, diagnosis, treatment, and palliative care of cancer patients through clinical research
Pivotal, the Madrid-based, European-wide Clinical Research Organization (CRO), is...
Pivotal and Palobiofarma collaborate on a novel mechanism of action oral treatment in asthma
New collaboration aims to further accelerate the delivery of investigational treatments for asthma
Pivotal and Palobiofarma announced today a new strategic collaboration to expand access of patients to novel...
Pivotal and APRO partner to develop 3 investigator sponsored trials in genitourinary tumors
Collaboration will further assess novel investigational cancer treatments combined with standard chemotherapy
PIVOTAL and APRO have announced today a close collaboration in 3 different oncology clinical trials to test...
Pivotal a rising star
Pivotal has been selected as one of the few firms that attracted recognition from the Pharma IQ network as a “RISING STAR"
We´re delighted to bring to...
Sarah Cannon development innovations collaborates with Pivotal on immuno-oncology trials
New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers in Europe
Sarah Cannon Development Innovations announced today a new strategic collaboration with Pivotal...
Pivotal has participated in the 36th annual JP Morgan healthcare conference
The annual conference was held in San Francisco (California)
Pivotal, represented by members of our Senior Management, has participated in the 36th Annual JP Morgan HealthCare Conference held in...